LANDON MARSHALL: Open Payments
NPI 1659035228 · NEWTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 11 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $315 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Lilly USA, LLC | 3 | $45 |
| ABBVIE INC. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: MOUNJARO, AIRSUPRA, VRAYLAR, XIFAXAN, BREZTRI, Rybelsus, PROQUAD, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
